查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572019

全球椎体成形术市场

Vertebroplasty
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球椎体成形术市场将达到4.267亿美元

全球椎体成形术市场预估2023年为2.875亿美元，预估至2030年将达4.267亿美元，2023-2030年分析期间复合年增长率为5.8%。

美国市场预估为7,630万美元，中国预期复合年增长率为8.5%

到 2023 年，美国椎体成形术市场预计将达到 7,630 万美元。中国作为全球第二大经济体，预计到 2030 年市场规模将达到 9,530 万美元，2023 年至 2030 年分析期间复合年增长率为 8.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.3% 和 5.5%。在欧洲，德国的复合年增长率预计为 3.4%。

全球椎体成形术市场趋势及驱动因素总结

什么是椎体成形术？

椎体成形术是一种尖端的微创手术技术，旨在治疗主要由骨质疏鬆症、转移性癌症和创伤引起的疼痛性椎体压迫性骨折 (VCF)。在这项手术中，一种特殊的丙烯酸骨水泥（最常见的是聚甲基丙烯酸甲酯（PMMA））被直接注射到骨折的脊椎骨中以稳定脊椎骨并快速缓解疼痛。在椎体成形术中，外科医生在连续、即时透视或 CT 影像引导下小心地将细针穿过皮肤插入骨折骨中，以精确注射骨水泥。骨水泥以半液体状态注入，并在脊椎骨内快速硬化，有效恢復结构完整性并减少引起疼痛的微运动。椎体成形术特别有吸引力的地方在于它可以立即且持续地缓解疼痛，使患者在手术后立即恢復正常活动。椎体成形术通常建议用于对休息、疼痛管理和矫正器具等保守治疗没有反应的患者，并且已成为改善椎体骨折患者生活品质的重要选择。此外，调查方法具有完善的安全性，且诊断影像技术、水泥成分和手术方法的最新进展大大降低了相关风险，使其在整形外科和神经外科领域中广泛接受。

椎体成形术的主要优点和挑战是什么？

儘管椎体成形术的好处是多方面的，并且为椎体压迫性骨折患者提供了显着的临床益处，但它并非没有挑战。它的主要优点之一是疼痛迅速且显着减轻，通常在手术后数小时内，因此患者比传统的开放性手术治疗体验到更大的缓解，可以快速恢復活动能力并恢復日常生活。这种恢復速度对于体力有限或患有多种使治疗复杂化的併发症的老年患者尤其重要。此外，透过稳定骨折的脊椎骨，椎体成形术可以防止脊椎进一步崩坏和畸形，从而降低脊椎后凸（通常称为「驼峰脂肪」）的风险。儘管有这些优点，椎体成形术在医学界还是引起了相当大的争议。主要原因是担心注射材料从椎体渗漏到邻近结构中，导致神经根受压、栓塞和脊髓损伤，从而产生潜在的併发症。为了降低这种风险，在改进水泥配方方面取得了进展，例如使用更高黏度的水泥和改进注射技术，以便在手术过程中更容易控制。另一个重要的挑战在于选择适当的椎体成形术任务，因为效果因骨折的根本原因而异。椎体成形术在治疗骨质疏鬆性骨折方面显示出优异的效果，但其治疗恶性病变或高衝击力创伤引起的骨折的有效性仍在研究中，需要强调准确的患者评估和个体化治疗计划的必要性。

椎体成形术与其他治疗方法相比如何？

儘管椎体成形术因其独特的优点而成为某些类型椎体压迫性骨折的首选治疗方法，但它经常与其他技术（例如后凸成形术和脊椎融合手术）进行比较，与其他治疗方法相比，每种技术都有其自身的优点和限制。一种相关的手术，后凸成形术，在註射水泥之前使用球囊压实在脊椎骨内形成空腔，以恢復一些失去的脊椎骨高度并矫正脊柱畸形。骨骺成形术在减少脊椎弯曲和预防姿势异常方面更有效，但通常比椎体成形术更昂贵且耗时。相较之下，椎体成形术更容易、更快、更便宜，因为骨水泥是直接注射的。脊椎融合手术是一种更具侵入性的手术选择，通常仅在涉及多个脊椎骨的严重病例或脊椎严重不稳定性时才进行。该手术使用骨移植物和金属硬体永久连接两个或多个脊椎骨，这增加了复杂性、恢復时间和潜在的併发症。由于椎体成形术是微创手术，因此在局部麻醉下进行，并且通常在门诊病人进行，这对于无法忍受侵入性手术所需的长时间麻醉或住院的老年或内科患者来说是理想的选择。患者。此外，椎体成形术缓解疼痛和稳定骨折的成功率与更具侵入性的手术相当或更好，特别是对于快速缓解疼痛和恢復正常功能来说，如果这是您的主要治疗目标，那么这是一个非常有利的选择。然而，这些方案的选择取决于多种因素，包括椎体崩坏的程度、整体骨骼健康状况以及在对每种治疗方法的风险和益处进行彻底讨论后患者的具体偏好。

哪些市场动态正在影响椎体成形术的发展？

椎体成形术市场的成长也受到多种因素的推动，例如骨质疏鬆症和相关椎体骨折盛行率的上升、手术技术的进步以及患者对微创治疗方案的偏好的改变。全球老化是推动椎体成形术需求的关键因素，因为骨质疏鬆症在老年人中尤其普遍，尤其是停经后女性，导致需要治疗椎体压迫性骨折的患者数量急剧增加。此外，生物活性和渗透性水泥等创新水泥配方的引入提高了手术的安全性和结果，使椎体成形术对患者和医疗保健专业人员都更具吸引力。此外，诊断影像技术的改进，包括采用高清透视和即时 3D 成像，正在提高手术的精确度，并降低併发症和骨水泥渗漏的风险。此外，对门诊治疗和门诊手术的日益偏好也有助于市场扩张。椎体成形术通常无需延长住院时间即可进行，从而降低了整体医疗成本并提高了患者满意度。消费者行为趋势表明，对恢復更快、对日常生活干扰更少的治疗的需求不断增长，进一步推动了椎体成形术的采用。医疗保健专业人员和患者对椎体骨折早期疗育益处的认识不断提高，导致了更积极的治疗策略并扩大了潜在的患者群体。此外，新市场参与者的进入以及主要相关人员之间的战略伙伴关係预计将增加竞争，促进创新，并使椎体成形术更容易获得和成本更低。因此，在人口趋势、技术创新以及不断变化的患者和提供者偏好的支持下，椎体成形术市场在未来几年将强劲成长。

受访企业范例（共42家）

  • Alphatec Spine, Inc.
  • DePuy Synthes（Johnson & Johnson）
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS（BMK Global Medical Company）
  • Stryker Corporation
  • Zavation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP17642

Global Vertebroplasty Market to Reach US$426.7 Million by 2030

The global market for Vertebroplasty estimated at US$287.5 Million in the year 2023, is expected to reach US$426.7 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$76.3 Million While China is Forecast to Grow at 8.5% CAGR

The Vertebroplasty market in the U.S. is estimated at US$76.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$95.3 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Vertebroplasty Market - Key Trends and Drivers Summarized

What Is Vertebroplasty and How Does It Work?

Vertebroplasty is a cutting-edge, minimally invasive surgical procedure developed to treat painful vertebral compression fractures (VCFs) caused primarily by osteoporosis, metastatic cancers, or trauma. This procedure entails injecting a specialized acrylic bone cement, most commonly polymethylmethacrylate (PMMA), directly into the fractured vertebra to stabilize it and provide rapid pain relief. During vertebroplasty, the surgeon carefully inserts a thin needle through the skin into the fractured bone under continuous real-time fluoroscopic or CT imaging guidance to ensure precise placement of the cement. The cement is injected in a semi-liquid state and quickly hardens inside the vertebra, effectively restoring its structural integrity and reducing micromovements that are the source of pain. What makes vertebroplasty especially appealing is its ability to provide immediate and lasting pain relief, allowing patients to resume normal activities shortly after the procedure. It is typically recommended for patients who have not responded to conservative management, such as bed rest, pain medication, and bracing, making it a critical option for improving the quality of life in individuals with debilitating spinal fractures. Additionally, vertebroplasty has a well-established safety profile, and recent advancements in imaging techniques, cement composition, and procedural methodologies have significantly reduced the associated risks, making it a widely accepted therapeutic option in the orthopedic and neurosurgical communities.

What Are the Major Benefits and Challenges of Vertebroplasty?

The advantages of vertebroplasty are multifaceted, providing substantial clinical benefits to patients with vertebral compression fractures, yet the procedure is not without its challenges. One of its primary benefits is the rapid and significant reduction of pain, which often occurs within hours post-procedure, enabling patients to regain mobility and return to their daily routines much faster than traditional open surgical treatments. This accelerated recovery is particularly crucial for elderly patients with limited physical capacity and those who suffer from multiple comorbidities that complicate their treatment. Furthermore, by stabilizing the fractured vertebra, vertebroplasty prevents further collapse and deformation of the spine, reducing the risk of progressive kyphosis, commonly known as a "dowager’s hump." Despite these benefits, vertebroplasty has sparked considerable debate in the medical community, primarily due to concerns regarding cement leakage—a complication that occurs when the injected material extrudes from the vertebral body into adjacent structures, potentially causing nerve root compression, embolism, or spinal cord injury. To mitigate these risks, there have been advancements in cement formulations, including the use of higher viscosity cements and refined injection techniques that allow for better control during the procedure. Another significant challenge lies in the selection of appropriate candidates for vertebroplasty, as its efficacy varies depending on the underlying cause of the fracture. While it has shown excellent outcomes in treating osteoporotic fractures, its effectiveness in fractures caused by malignant lesions or high-impact trauma remains a subject of ongoing research, highlighting the need for precise patient evaluation and individualized treatment planning.

How Does Vertebroplasty Compare to Other Treatment Options?

Vertebroplasty stands out as a preferred treatment for certain types of vertebral compression fractures due to its unique benefits, but it is often compared to other procedures like kyphoplasty and spinal fusion, each of which has its own strengths and limitations. Kyphoplasty, a related procedure, involves the use of a balloon tamp to create a cavity within the vertebra before cement is injected, which helps to restore some of the lost vertebral height and correct spinal deformity. While kyphoplasty is more effective in reducing spinal curvature and preventing postural abnormalities, it is typically more expensive and time-consuming than vertebroplasty. Vertebroplasty, by contrast, involves direct cement injection, making it simpler, faster, and less costly. Spinal fusion, a more invasive surgical option, is usually reserved for severe cases involving multiple vertebrae or when there is significant spinal instability. This procedure involves placing bone grafts and metallic hardware to permanently join two or more vertebrae, which increases the complexity, recovery time, and the potential for complications. Due to its minimally invasive nature, vertebroplasty is performed under local anesthesia and often as an outpatient procedure, making it an ideal choice for elderly or medically fragile patients who cannot tolerate the prolonged anesthesia or hospitalization required for more invasive surgeries. Moreover, vertebroplasty’s success rate in alleviating pain and stabilizing the fracture is comparable to or even exceeds that of more invasive techniques, making it a highly favorable option, especially when quick pain relief and a return to normal function are primary treatment goals. However, the choice between these options depends on various factors such as the degree of vertebral collapse, overall bone health, and patient-specific preferences following a thorough discussion of the risks and benefits of each treatment modality.

What Are the Market Dynamics Shaping Vertebroplasty Growth?

The growth in the vertebroplasty market is driven by several factors, including the rising prevalence of osteoporosis and related vertebral fractures, advancements in procedural technology, and shifting patient preferences towards less invasive treatment options. The global aging population is a key driver of demand for vertebroplasty, as osteoporosis is particularly prevalent among older adults, especially postmenopausal women, leading to a surge in the number of patients requiring treatment for vertebral compression fractures. Furthermore, the introduction of innovative cement formulations, such as bioactive and radiopaque cements, has improved procedural safety and outcomes, making vertebroplasty a more attractive option for both patients and healthcare providers. Additionally, improvements in imaging techniques, including the adoption of high-definition fluoroscopy and real-time 3D imaging, have enhanced procedural precision, reducing the risk of complications and cement leakage. The growing preference for outpatient and ambulatory surgical settings has also contributed to the market expansion, as vertebroplasty can often be performed without the need for prolonged hospitalization, thereby reducing overall healthcare costs and increasing patient satisfaction. Consumer behavior trends indicate a rising demand for treatments that offer rapid recovery and minimal disruption to daily life, further fueling the adoption of vertebroplasty. Increased awareness among healthcare professionals and patients about the benefits of early intervention for spinal fractures has led to more proactive treatment strategies, expanding the potential patient base. Furthermore, the entry of new market players and strategic partnerships among key stakeholders are expected to boost competition, foster innovation, and drive down costs, making vertebroplasty more accessible. As a result, the vertebroplasty market is poised for robust growth in the coming years, supported by a combination of demographic trends, technological innovations, and evolving patient and provider preferences.

Select Competitors (Total 42 Featured) -

  • Alphatec Spine, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS (BMK Global Medical Company)
  • Stryker Corporation
  • Zavation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Vertebroplasty - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Spinal Compression Fractures Accelerates Vertebroplasty Adoption
    • Rising Geriatric Population Spurs Demand for Vertebroplasty Procedures
    • Increased Awareness of Minimally Invasive Spine Treatments Expands Market Opportunities
    • Advancements in Imaging Technology Drive Adoption of Precision-Guided Vertebroplasty
    • Shift Towards Minimally Invasive Techniques Over Traditional Open Surgeries Fuels Market Growth
    • Increasing Focus on Outpatient Settings Expands Market Reach for Vertebroplasty Services
    • Innovations in Bioactive Bone Cements Generate New Product Demand
    • Growing Popularity of Personalized, Patient-Specific Solutions Propels Market Expansion
    • Heightened Need for Effective Pain Management in Oncology Patients Increases Vertebroplasty Utilization
    • Wider Physician Training Programs Enhance Market Penetration of Vertebroplasty Procedures
    • Patient Preference for Shorter Recovery Time and Minimally Invasive Options Drives Adoption
    • Surging Healthcare Investments in Emerging Markets Open New Growth Opportunities
    • High Costs and Risk of Procedure-Related Complications Present Market Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Vertebroplasty Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION